Ligand Pharmaceuticals | LGND - EPS Earnings Per Share


Ligand Pharmaceuticals reported $2.02 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.82 1.33 May/06
FY2025Q4 Dec/2025 2.02 1.49 1.27 Feb/26
FY2025Q3 Sep/2025 3.09 1.93 1.84 Nov/06
FY2025Q2 Jun/2025 1.60 1.43 1.40 Aug/07
FY2025Q1 Mar/2025 1.33 1.22 1.20 May/08




Eps Change Date
Agenus USD -0.3 0.84 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Baxter International USD 0.44 0.25 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Enviri Corporation USD -1.02 0.92 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Glaxosmithkline GBP 0.21 0.51 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Intrexon USD -0.1 0.03 Jun/2024
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Pacira USD 0.06 0.64 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Veracyte USD 0.53 0.02 Dec/2025